{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:02:39Z","timestamp":1789520559413,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":102,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20399"],"award-info":[{"award-number":["U23A20399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071164"],"award-info":[{"award-number":["32071164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7242006"],"award-info":[{"award-number":["7242006"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01425-5","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:44:38Z","timestamp":1780775078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabotropic signaling downstream of GABAA receptors suppresses neuroinflammation in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Wenjing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenqin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"1425_CR1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii, A., Nutt, J. G. & Ransom, B. R. Parkinson\u2019s disease. Lancet 363, 1783\u20131793 (2004).","journal-title":"Lancet"},{"key":"1425_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbi.2016.02.001","volume":"54","author":"T Crowley","year":"2016","unstructured":"Crowley, T., Cryan, J. F., Downer, E. J. & O\u2019Leary, O. F. Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions. Brain Behav. Immun. 54, 260\u2013277 (2016).","journal-title":"Brain Behav. Immun."},{"key":"1425_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1425_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target Ther. 8, 267 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"1425_CR5","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","volume":"15","author":"X Han","year":"2019","unstructured":"Han, X. et al. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Autophagy 15, 1860\u20131881 (2019).","journal-title":"Autophagy"},{"key":"1425_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9, 226 (2021).","journal-title":"Microbiome"},{"key":"1425_CR7","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","volume":"11","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4\/MyD88\/NF-\u03baB pathway through microbiota-gut-brain axis. Acta Pharm. Sin. B 11, 2859\u20132879 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"1425_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02494-y","volume":"19","author":"L Kou","year":"2022","unstructured":"Kou, L. et al. The circadian clock protein Rev-erb\u03b1 provides neuroprotection and attenuates neuroinflammation against Parkinson\u2019s disease via the microglial NLRP3 inflammasome. J. Neuroinflamm. 19, 133 (2022).","journal-title":"J. Neuroinflamm."},{"key":"1425_CR9","doi-asserted-by":"crossref","unstructured":"Chavarr\u00eda, C., Ivagnes, R. & Souza, J.M. Extracellular alpha-synuclein: mechanisms for glial cell internalization and activation. Biomolecules 12, 655 (2022).","DOI":"10.3390\/biom12050655"},{"key":"1425_CR10","doi-asserted-by":"publisher","first-page":"9259646","DOI":"10.1155\/2016\/9259646","volume":"2016","author":"P Rider","year":"2016","unstructured":"Rider, P., Carmi, Y. & Cohen, I. Biologics for targeting inflammatory cytokines, clinical uses, and limitations. Int. J. Cell Biol. 2016, 9259646 (2016).","journal-title":"Int. J. Cell Biol."},{"key":"1425_CR11","doi-asserted-by":"crossref","unstructured":"Rees, K. et al. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson\u2019s disease: evidence from observational studies. Cochrane Database Syst. Rev. 11, Cd008454 (2011).","DOI":"10.1002\/14651858.CD008535.pub2"},{"key":"1425_CR12","doi-asserted-by":"publisher","first-page":"d198","DOI":"10.1136\/bmj.d198","volume":"342","author":"JA Driver","year":"2011","unstructured":"Driver, J. A. et al. Use of non-steroidal anti-inflammatory drugs and risk of Parkinson\u2019s disease: nested case-control study. Bmj 342, d198 (2011).","journal-title":"Bmj"},{"key":"1425_CR13","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1073\/pnas.0915139107","volume":"107","author":"R Bhat","year":"2010","unstructured":"Bhat, R. et al. Inhibitory role for GABA in autoimmune inflammation. Proc. Natl. Acad. Sci. USA 107, 2580\u20132585 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1425_CR14","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.autrev.2015.07.011","volume":"14","author":"GJ Prud\u2019homme","year":"2015","unstructured":"Prud\u2019homme, G. J., Glinka, Y. & Wang, Q. Immunological GABAergic interactions and therapeutic applications in autoimmune diseases. Autoimmun. Rev. 14, 1048\u20131056 (2015).","journal-title":"Autoimmun. Rev."},{"key":"1425_CR15","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.2337\/db13-1236","volume":"63","author":"S Robert","year":"2014","unstructured":"Robert, S. et al. Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes 63, 2876\u20132887 (2014).","journal-title":"Diabetes"},{"key":"1425_CR16","doi-asserted-by":"crossref","unstructured":"Meiron, O. Common genomic and proteomic alterations related to disturbed neural oscillatory activity in schizophrenia. Int. J. Mol. Sci. 26, 7514 (2025).","DOI":"10.3390\/ijms26157514"},{"key":"1425_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1254\/jjp.48.331","volume":"48","author":"N Nishino","year":"1988","unstructured":"Nishino, N., Fujiwara, H., Noguchi-Kuno, S. A. & Tanaka, C. GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson\u2019s disease. Jpn J. Pharm. 48, 331\u2013339 (1988).","journal-title":"Jpn J. Pharm."},{"key":"1425_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00002826-200405000-00007","volume":"27","author":"N Van Blercom","year":"2004","unstructured":"Van Blercom, N. et al. Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease. Clin. Neuropharmacol. 27, 124\u2013128 (2004).","journal-title":"Clin. Neuropharmacol."},{"key":"1425_CR19","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1093\/brain\/124.10.2105","volume":"124","author":"R Levy","year":"2001","unstructured":"Levy, R. et al. Lidocaine and muscimol microinjections in subthalamic nucleus reverse Parkinsonian symptoms. Brain 124, 2105\u20132118 (2001).","journal-title":"Brain"},{"key":"1425_CR20","volume":"2016","author":"A Daniele","year":"2016","unstructured":"Daniele, A. et al. Can a positive allosteric modulation of GABAergic receptors improve motor symptoms in patients with Parkinson\u2019s disease? The potential role of zolpidem in the treatment of Parkinson\u2019s Disease. Parkinsons Dis. 2016, 2531812 (2016).","journal-title":"Parkinsons Dis."},{"key":"1425_CR21","doi-asserted-by":"publisher","first-page":"e15973","DOI":"10.1371\/journal.pone.0015973","volume":"6","author":"AM Fontainhas","year":"2011","unstructured":"Fontainhas, A. M. et al. Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PLoS One 6, e15973 (2011).","journal-title":"PLoS One"},{"key":"1425_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jneuroim.2017.09.012","volume":"313","author":"N Fernandez Hurst","year":"2017","unstructured":"Fernandez Hurst, N. et al. Diazepam treatment reduces inflammatory cells and mediators in the central nervous system of rats with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 313, 145\u2013151 (2017).","journal-title":"J. Neuroimmunol."},{"key":"1425_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2015.04.001","volume":"282","author":"RD Sanders","year":"2015","unstructured":"Sanders, R. D. et al. Immune cell expression of GABAA receptors and the effects of diazepam on influenza infection. J. Neuroimmunol. 282, 97\u2013103 (2015).","journal-title":"J. Neuroimmunol."},{"key":"1425_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/pr.108.00505","volume":"60","author":"RW Olsen","year":"2008","unstructured":"Olsen, R. W. & Sieghart, W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update Pharm. Rev. 60, 243\u2013260 (2008).","journal-title":"Update Pharm. Rev."},{"key":"1425_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1126\/science.290.5489.131","volume":"290","author":"K L\u00f6w","year":"2000","unstructured":"L\u00f6w, K. et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131\u2013134 (2000).","journal-title":"Science"},{"key":"1425_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","volume":"6","author":"U Rudolph","year":"2006","unstructured":"Rudolph, U. & M\u00f6hler, H. GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr. Opin. Pharmacol. 6, 18\u201323 (2006).","journal-title":"Curr. Opin. Pharmacol."},{"key":"1425_CR27","doi-asserted-by":"crossref","unstructured":"Lan, J. et al. The activation of GABA A R alleviated cerebral ischemic injury via the suppression of oxidative stress, autophagy, and apoptosis pathways. Antioxidants 13, 194 (2024).","DOI":"10.3390\/antiox13020194"},{"key":"1425_CR28","doi-asserted-by":"publisher","first-page":"e113610","DOI":"10.1371\/journal.pone.0113610","volume":"9","author":"A Kakehashi","year":"2014","unstructured":"Kakehashi, A. et al. Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signaling. PLOS One 9, e113610 (2014).","journal-title":"PLOS One"},{"key":"1425_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep15720","volume":"5","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. Tiagabine protects dopaminergic neurons against neurotoxins by inhibiting microglial activation. Sci. Rep. 5, 15720 (2015).","journal-title":"Sci. Rep."},{"key":"1425_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/glia.21087","volume":"59","author":"M Lee","year":"2011","unstructured":"Lee, M., Schwab, C. & McGeer, P. L. Astrocytes are GABAergic cells that modulate microglial activity. Glia 59, 152\u2013165 (2011).","journal-title":"Glia"},{"key":"1425_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu, H. et al. Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct. Target Ther. 5, 209 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1425_CR32","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.4049\/jimmunol.170.11.5630","volume":"170","author":"F Yang","year":"2003","unstructured":"Yang, F., Tang, E., Guan, K. & Wang, C. Y. IKK beta plays an essential role in the phosphorylation of RelA\/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170, 5630\u20135635 (2003).","journal-title":"J. Immunol."},{"key":"1425_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu, H. et al. Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct. Target Ther. 5, 209 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1425_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.557647","volume":"13","author":"Y Dong","year":"2020","unstructured":"Dong, Y. et al. Nicotine prevents oxidative stress-induced hippocampal neuronal injury through alpha7-nAChR\/Erk1\/2 signaling pathway. Front. Mol. Neurosci. 13, 557647 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"1425_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/jmcb\/mjv049","volume":"7","author":"J Blondelle","year":"2015","unstructured":"Blondelle, J. et al. HACD1, a regulator of membrane composition and fluidity, promotes myoblast fusion and skeletal muscle growth. J. Mol. Cell Biol. 7, 429\u2013440 (2015).","journal-title":"J. Mol. Cell Biol."},{"key":"1425_CR36","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1002\/1873-3468.12912","volume":"591","author":"Y Tsuchiya","year":"2017","unstructured":"Tsuchiya, Y. et al. Distinct B subunits of PP2A regulate the NF-kappaB signalling pathway through dephosphorylation of IKKbeta, IkappaBalpha and RelA. FEBS Lett. 591, 4083\u20134094 (2017).","journal-title":"FEBS Lett."},{"key":"1425_CR37","doi-asserted-by":"publisher","first-page":"38620","DOI":"10.1074\/jbc.M004531200","volume":"275","author":"S Pons","year":"2000","unstructured":"Pons, S. & Torres-Aleman, I. Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B). J. Biol. Chem. 275, 38620\u201338625 (2000).","journal-title":"J. Biol. Chem."},{"key":"1425_CR38","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbrc.2003.09.174","volume":"311","author":"S Feske","year":"2003","unstructured":"Feske, S., Okamura, H., Hogan, P. G. & Rao, A. Ca2+\/calcineurin signalling in cells of the immune system. Biochem. Biophys. Res Commun. 311, 1117\u20131132 (2003).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"1425_CR39","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/cr.2013.77","volume":"23","author":"N Wlodarchak","year":"2013","unstructured":"Wlodarchak, N. et al. Structure of the Ca2+-dependent PP2A heterotrimer and insights into Cdc6 dephosphorylation. Cell Res. 23, 931\u2013946 (2013).","journal-title":"Cell Res."},{"key":"1425_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0030221","volume":"3","author":"M Graupner","year":"2007","unstructured":"Graupner, M. & Brunel, N. STDP in a bistable synapse model based on CaMKII and associated signaling pathways. PLoS Comput. Biol. 3, e221 (2007).","journal-title":"PLoS Comput. Biol."},{"key":"1425_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06487-5","volume":"9","author":"JK Kim","year":"2018","unstructured":"Kim, J. K. et al. GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat. Commun. 9, 4184 (2018).","journal-title":"Nat. Commun."},{"key":"1425_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.molcel.2008.06.018","volume":"31","author":"SN Hicks","year":"2008","unstructured":"Hicks, S. N. et al. General and versatile autoinhibition of PLC isozymes. Mol. Cell 31, 383\u2013394 (2008).","journal-title":"Mol. Cell"},{"key":"1425_CR43","doi-asserted-by":"crossref","unstructured":"Negri, S. et al. GABA(A) and GABA(B) receptors mediate GABA-induced intracellular Ca(2+) signals in human brain microvascular endothelial cells. Cells 11, 3860 (2022).","DOI":"10.3390\/cells11233860"},{"key":"1425_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1471-4159.2006.04206.x","volume":"100","author":"ZW Chen","year":"2007","unstructured":"Chen, Z. W. & Olsen, R. W. GABAA receptor associated proteins: a key factor regulating GABAA receptor function. J. Neurochem. 100, 279\u2013294 (2007).","journal-title":"J. Neurochem."},{"key":"1425_CR45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","volume":"565","author":"S Masiulis","year":"2019","unstructured":"Masiulis, S. et al. GABA(A) receptor signalling mechanisms revealed by structural pharmacology. Nature 565, 454\u2013459 (2019).","journal-title":"Nature"},{"key":"1425_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","volume":"599","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity. Nature 599, 471\u2013476 (2021).","journal-title":"Nature"},{"key":"1425_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.yfrne.2013.03.001","volume":"34","author":"F di Michele","year":"2013","unstructured":"di Michele, F. et al. Neurosteroid and neurotransmitter alterations in Parkinson\u2019s disease. Front. Neuroendocrinol. 34, 132\u2013142 (2013).","journal-title":"Front. Neuroendocrinol."},{"key":"1425_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.574706","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Post-translational modifications of I\u03baB\u03b1: the state of the art. Front. Cell Dev. Biol. 8, 574706 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1425_CR49","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1002\/1873-3468.12912","volume":"591","author":"Y Tsuchiya","year":"2017","unstructured":"Tsuchiya, Y. et al. Distinct B subunits of PP2A regulate the NF-\u03baB signalling pathway through dephosphorylation of IKK\u03b2, I\u03baB\u03b1 and RelA. FEBS Lett. 591, 4083\u20134094 (2017).","journal-title":"FEBS Lett."},{"key":"1425_CR50","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1111\/bph.14057","volume":"174","author":"X Han","year":"2017","unstructured":"Han, X. et al. Dopamine D(2) receptor signalling controls inflammation in acute pancreatitis via a PP2A-dependent Akt\/NF-\u03baB signalling pathway. Br. J. Pharm. 174, 4751\u20134770 (2017).","journal-title":"Br. J. Pharm."},{"key":"1425_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/08923973.2021.2023174","volume":"44","author":"FN Cankara","year":"2022","unstructured":"Cankara, F. N. et al. The beneficial effect of salubrinal on neuroinflammation and neuronal loss in intranigral LPS-induced hemi-Parkinson disease model in rats. Immunopharmacol. Immunotoxicol. 44, 168\u2013177 (2022).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"1425_CR52","doi-asserted-by":"publisher","first-page":"21667","DOI":"10.1074\/jbc.M110.201582","volume":"286","author":"C Porcher","year":"2011","unstructured":"Porcher, C. et al. Positive feedback regulation between gamma-aminobutyric acid type A (GABA(A)) receptor signaling and brain-derived neurotrophic factor (BDNF) release in developing neurons. J. Biol. Chem. 286, 21667\u201321677 (2011).","journal-title":"J. Biol. Chem."},{"key":"1425_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.pharmtox.46.120604.141223","volume":"46","author":"TK Harden","year":"2006","unstructured":"Harden, T. K. & Sondek, J. Regulation of phospholipase C isozymes by ras superfamily GTPases. Annu Rev. Pharm. Toxicol. 46, 355\u2013379 (2006).","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"1425_CR54","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41380-018-0100-y","volume":"23","author":"MW Nicholson","year":"2018","unstructured":"Nicholson, M. W. et al. Diazepam-induced loss of inhibitory synapses mediated by PLC\u03b4\/ Ca2+\/calcineurin signalling downstream of GABAA receptors. Mol. Psychiatry 23, 1851\u20131867 (2018).","journal-title":"Mol. Psychiatry"},{"key":"1425_CR55","doi-asserted-by":"crossref","unstructured":"Tuzi, S. et al. Structure and dynamics of the phospholipase C-\u03b41 pleckstrin homology domain located at the lipid bilayer surface. J. Biol. Chem. 278, 28019\u201328025 (2003).","DOI":"10.1074\/jbc.M300101200"},{"key":"1425_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tibs.2010.08.003","volume":"36","author":"TD Bunney","year":"2011","unstructured":"Bunney, T. D. & Katan, M. PLC regulation: emerging pictures for molecular mechanisms. Trends Biochem Sci. 36, 88\u201396 (2011).","journal-title":"Trends Biochem Sci."},{"key":"1425_CR57","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/nsmb1175","volume":"13","author":"MR Jezyk","year":"2006","unstructured":"Jezyk, M. R. et al. Crystal structure of Rac1 bound to its effector phospholipase C-beta2. Nat. Struct. Mol. Biol. 13, 1135\u20131140 (2006).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1425_CR58","doi-asserted-by":"publisher","first-page":"e0149991","DOI":"10.1371\/journal.pone.0149991","volume":"11","author":"F Song","year":"2016","unstructured":"Song, F. et al. Schizandrin A inhibits microglia-mediated neuroninflammation through inhibiting TRAF6-NF-\u03baB and Jak2-Stat3 signaling pathways. PLoS One 11, e0149991 (2016).","journal-title":"PLoS One"},{"key":"1425_CR59","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.omtn.2019.07.008","volume":"17","author":"X Ren","year":"2019","unstructured":"Ren, X. et al. Exosomal DNA aptamer targeting \u03b1-synuclein aggregates reduced neuropathological deficits in a mouse Parkinson\u2019s disease model. Mol. Ther. Nucleic Acids 17, 726\u2013740 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1425_CR60","doi-asserted-by":"publisher","first-page":"113608","DOI":"10.1016\/j.ab.2020.113608","volume":"593","author":"L Pillai-Kastoori","year":"2020","unstructured":"Pillai-Kastoori, L., Schutz-Geschwender, A. R. & Harford, J. A. A systematic approach to quantitative Western blot analysis. Anal. Biochem. 593, 113608 (2020).","journal-title":"Anal. Biochem."},{"key":"1425_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1126\/scitranslmed.aah4066","volume":"10","author":"R Gordon","year":"2018","unstructured":"Gordon, R. et al. Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med. 10, 12 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1425_CR62","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41401-020-0358-x","volume":"41","author":"JQ Liu","year":"2020","unstructured":"Liu, J. Q. et al. Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-\u03baB signaling and modulation of M1\/M2 polarization. Acta Pharmacol. Sin. 41, 523\u2013534 (2020).","journal-title":"Acta Pharmacol. Sin."},{"key":"1425_CR63","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1523\/JNEUROSCI.19-21-09228.1999","volume":"19","author":"NJ Brandon","year":"1999","unstructured":"Brandon, N. J. et al. Subunit-specific association of protein kinase C and the receptor for activated C kinase with GABA type A receptors. J. Neurosci. 19, 9228\u20139234 (1999).","journal-title":"J. Neurosci."},{"key":"1425_CR64","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","volume":"19","author":"R Lin","year":"2022","unstructured":"Lin, R. et al. Directed evolution of adeno-associated virus for efficient gene delivery to microglia. Nat. Methods 19, 976\u2013985 (2022).","journal-title":"Nat. Methods"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01425-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:03:15Z","timestamp":1789516995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01425-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1425"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01425-5","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"221"}}